Concepedia

R. Kast

RK

Statistics

Publications

8

Citations

451

H-Index

8

Active since

1992

Affiliations

Bayer (Germany)(Current)

Heidelberg University

German Cancer Research Center

Target (Germany)

R. Kast is an author at Bayer (Germany) specializing in medicine, pharmacology, and oxidative stress.

Top concepts

Publications per year

1992–2012

8

Publications

8

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT<sub>2</sub>) receptor

Frank Wunder, Hanna Tinel, R. Kast et al. · British Journal of Pharmacology · 2010 · 76 citations · Full text

Activation of cytosolic phospholipase A2 by transforming growth factor-alpha in HEL-30 keratinocytes

R. Kast, Gerhard Fürstenberger, Friedrich Marks · Journal of Biological Chemistry · 1993 · 74 citations · Full text

Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling

Stephan Schäfer, Peter Ellinghaus, Wiebke Janssen et al. · Cardiovascular Research · 2009 · 69 citations · Full text

Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase

R. Kast, Hartmut Schirok, Santiago Figueroa‐Pérez et al. · British Journal of Pharmacology · 2007 · 65 citations · Full text

Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension

Bhola K. Dahal, Djuro Kosanovic, Pavan Kumar Pamarthi et al. · European Respiratory Journal · 2010 · 52 citations · Full text

, , +19

1–5 of 8